Search Results - "Grossman, Ronald F."

Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones by Grossman, Ronald F, Hsueh, Po-Ren, Gillespie, Stephen H, Blasi, Francesco

“…Summary The respiratory fluoroquinolones moxifloxacin, gemifloxacin, and high-dose levofloxacin are recommended in guidelines for effective empirical…”
Get full text

Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society by Mandell, Lionel A., Marrie, Thomas J., Grossman, Ronald F., Chow, Anthony W., Hyland, Robert H.

Get full text

Rare Presentation of Pulmonary Alveolar Proteinosis Causing Acute Respiratory Failure by Price, Charles, Grossman, Ronald F., Kumar, Sameer, Kroll, Ryan R., Srigley, John R.

“…Pulmonary alveolar proteinosis (PAP) is a rare condition characterized by dysfunctional alveolar macrophages, which ineffectively clear surfactant and…”
Get full text

Pulmonary blastomycosis in a professional diver: an occupational risk by Kroll, Ryan R, Grossman, Ronald F

“…In certain parts of the United States and Canada, and northern Ontario in particular, the dimorphic fungus Blastomyces dermatitidis is endemic and can cause…”
Get full text

Antimicrobial treatment of lower respiratory tract infections in the hospital setting by Grossman, Ronald F, Rotschafer, John C, Tan, James S

“…Respiratory tract infections (RTIs) that may require hospitalization include acute exacerbations of chronic bronchitis (AECB), community-acquired pneumonia…”
Get more information

Canadian guidelines for the management of acute exacerbations of chronic bronchitis by Balter, Meyer S, La Forge, Jacques, Low, Donald E, Mandell, Lionel, Grossman, Ronald F

“…Acute exacerbations of chronic bronchitis (AECB) account for over 1.5 million physician visits annually in Canada and are a cause of significant morbidity and…”
Get full text

The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD by Grossman, R F

“…COPD is the fifth leading cause of death in the United States, and acute respiratory infections account for a significant proportion of all primary care…”
Get more information

Do we know the minimal clinically important difference (MCID) for COPD exacerbations? by Chapman, Kenneth R, Bergeron, Celine, Bhutani, Mohit, Bourbeau, Jean, Grossman, Ronald F, Hernandez, Paul, McIvor, R Andrew, Mayers, Irvin

“…Frequent exacerbations of COPD are associated with accelerated loss of lung function, declining health status, increased mortality, and increased health care…”
Get more information

How do we achieve cost-effective options in lower respiratory tract infection therapy? by Grossman, R F

“…Acute bronchitis and acute exacerbations of chronic bronchitis, common illnesses encountered by general and family physicians, account for approximately 14…”
Get more information

Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease by SPENCER, Michael, BRIGGS, Andrew H, GROSSMAN, Ronald F, RANCE, Laureen

“…To develop a Markov model that allows the cost effectiveness of interventions in patients with chronic obstructive pulmonary disease (COPD) to be estimated,…”
Get full text

The Infection-Free Interval: Its Use in Evaluating Antimicrobial Treatment of Acute Exacerbation of Chronic Bronchitis by Anzueto, Antonio, Rizzo, John A., Grossman, Ronald F.

Get full text

Short-course fluoroquinolones in acute exacerbations of chronic bronchitis by Gotfried, Mark H, Grossman, Ronald F

“…It is estimated that 50-70% of acute exacerbations of chronic bronchitis (AECB) are caused by bacterial infections. Appropriate selection of antimicrobials may…”
Get more information

New Role of Quinolones in Respiratory Tract Infections by Ronald F Grossman

“…Because of limited activity of the standard quinolones such as ciprofloxacin and ofloxacin against some clinically important organisms including Streptococcus…”
Get full text

Guidelines for the treatment of acute exacerbations of chronic bronchitis by Grossman, R F

Get more information

Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: A post hoc analysis of data from severely ill patients by Grossman, Ronald F., Ambrusz, Mary E., Fisher, Alan C., Khashab, Mohammed M., Kahn, James B.

“…This post hoc analysis of data from a previous randomized, blinded, multicenter, parallel, noninferiority study assessed the bacterial etiology, symptom…”
Get full text

Blood eosinophils in COPD to predict exacerbations and inform inhaled corticosteroid use: Need for further evidence? by Grossman, Ronald F.

“…Chronic obstructive pulmonary disease (COPD) is a progressive respiratory illness characterized by breathing difficulty and restricted lung air flow. Its…”
Get full text

Woman with chronic, unproductive cough and left lower lobe lung mass by Grossman, Ronald F

Get more information

The Role of Quinolones in Upper Respiratory Tract Infections by Grossman, Ronald F.

“…Fluoroquinolones are widely used in clinical practice because of their advanced pharmacokinetic properties, potential activity against most bacterial species,…”
Get full text

Transudative pleural effusions: false reassurance against malignancy by Moltyaner, Y, Miletin, M S, Grossman, R F

Get more information

Infectious complications following isolated lung transplantation by Maurer, J R, Tullis, D E, Grossman, R F, Vellend, H, Winton, T L, Patterson, G A

“…To ascertain the incidence, types, morbidity, and mortality of infectious episodes in isolated lung transplant recipients. Retrospective chart review of…”
Get more information